Mizuho Securities USA’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.25M Buy
6,176
+1,349
+28% +$757K 0.05% 323
2026
Q1
$2.71M Sell
4,827
-987
-17% -$633K 0.06% 322
2025
Q4
$4.38M Sell
5,814
-13
-0.2% -$8.85K 0.07% 239
2025
Q3
$3.77M Buy
5,827
+264
+5% +$160K 0.08% 261
2025
Q2
$2.98M Sell
5,563
-994
-15% -$475K 0.06% 298
2025
Q1
$2.75M Sell
6,557
-1,204
-16% -$523K 0.06% 313
2024
Q4
$3.21M Buy
7,761
+2,424
+45% +$1.06M 0.06% 308
2024
Q3
$2.7M Sell
5,337
-1,031
-16% -$501K 0.06% 285
2024
Q2
$3.1M Buy
+6,368
New +$3.2M 0.07% 262

Other funds holding IDXX

Mizuho Securities USA's IDXX Position: Q2 2026 in Review

Mizuho Securities USA increased its Idexx Laboratories (IDXX) stake by 28% in Q2 2026, buying an estimated $757K and bringing the position to 6,176 shares worth $3.25M. The position accounts for 0.05% of the portfolio, ranked #323.

Mizuho Securities USA first reported a position in IDXX in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.38M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Mizuho Securities USA held 6,176 shares of Idexx Laboratories worth $3.25M as of Q2 2026.
  • Mizuho Securities USA bought 1,349 Idexx Laboratories shares in Q2 2026, an estimated $757K.
  • Idexx Laboratories made up 0.05% of Mizuho Securities USA's portfolio in Q2 2026, its #323 holding.
  • Mizuho Securities USA first reported a position in Idexx Laboratories in Q2 2024 and has held it in 9 quarters since.
  • Mizuho Securities USA's Idexx Laboratories position peaked at $4.38M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.